Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | YTHDC1 | Q96MU7 | 5/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.43 |
| ▸ | CLK1 | P49759 | 2/20 | 0.43 |
| ▸ | CLK2 | P49760 | 2/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31707853 | 0.99 | YTHDC1 (0.49) | YTHDC1ADORA3ADORA2AADORA1CLK1 | |
| SCHEMBL17929772 | 0.87 | YTHDC1 (0.63) | YTHDC1ADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL28024961 | 0.86 | CTSL (0.41) | CLK1CLK2CLK4CDK1PRKCA | |
| Hydrochloric Acid SCHEMBL31707879 | 0.85 | CDK1 (0.43) | CLK1CLK2CLK4CDK1CTSL | |
| SCHEMBL23547543 | 0.80 | CTSL (0.46) | YTHDC1CDK1PRKCACTSLCTSB | |
| SCHEMBL31707865 | 0.79 | CDK2 (0.63) | CLK1CLK2CLK4CDK1 | |
| Hydrochloric Acid SCHEMBL31707861 | 0.79 | CDK2 (0.62) | CLK1CLK2CLK4CDK1 | |
| SCHEMBL31707891 | 0.79 | CDK2 (0.56) | CLK1CLK2CLK4CDK1 | |
| Hydrochloric Acid SCHEMBL31692643 | 0.79 | CDK2 (0.62) | CLK1CLK2CLK4CDK1 | |
| SCHEMBL31707907 | 0.79 | CDK2 (0.56) | CLK1CLK2CLK4CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4634186-A1 | 2,6,9-TRISUBSTITUTED PURINES | Astrazeneca AB (SE) | 2025-10-22 | — | — | EP | disclosed |